A detailed history of Nisa Investment Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 787,466 shares of JNJ stock, worth $114 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
787,466
Previous 671,123 17.34%
Holding current value
$114 Million
Previous $98.1 Million 30.1%
% of portfolio
0.77%
Previous 0.63%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$145.48 - $167.38 $16.9 Million - $19.5 Million
116,343 Added 17.34%
787,466 $128 Million
Q2 2024

Jul 19, 2024

SELL
$144.38 - $157.78 $534,927 - $584,574
-3,705 Reduced 0.55%
671,123 $98.1 Million
Q1 2024

May 01, 2024

SELL
$155.22 - $162.74 $1.66 Million - $1.74 Million
-10,671 Reduced 1.56%
674,828 $107 Million
Q4 2023

Jan 25, 2024

SELL
$145.6 - $158.88 $5.06 Million - $5.52 Million
-34,729 Reduced 4.82%
685,499 $107 Million
Q3 2023

Nov 02, 2023

SELL
$155.75 - $174.48 $4.02 Million - $4.5 Million
-25,806 Reduced 3.46%
720,228 $112 Million
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $433,414 - $466,436
-2,808 Reduced 0.37%
746,034 $123 Million
Q1 2023

May 02, 2023

BUY
$151.05 - $180.26 $1.03 Million - $1.23 Million
6,836 Added 0.92%
748,842 $116 Million
Q4 2022

Feb 02, 2023

SELL
$160.2 - $179.79 $2.54 Million - $2.85 Million
-15,858 Reduced 2.09%
742,006 $131 Million
Q3 2022

Nov 07, 2022

BUY
$161.33 - $179.52 $546,263 - $607,854
3,386 Added 0.45%
757,864 $124 Million
Q2 2022

Aug 03, 2022

SELL
$168.19 - $186.01 $2.35 Million - $2.6 Million
-13,994 Reduced 1.82%
754,478 $134 Million
Q1 2022

Apr 29, 2022

SELL
$158.14 - $179.59 $22.9 Million - $26 Million
-144,950 Reduced 15.87%
768,472 $136 Million
Q4 2021

Feb 03, 2022

BUY
$155.93 - $173.01 $21.2 Million - $23.5 Million
136,043 Added 17.5%
913,422 $157 Million
Q3 2021

Oct 18, 2021

SELL
$161.5 - $179.47 $1.31 Million - $1.46 Million
-8,130 Reduced 1.03%
777,379 $126 Million
Q2 2021

Aug 06, 2021

SELL
$159.48 - $171.07 $21.1 Million - $22.6 Million
-132,314 Reduced 14.42%
785,509 $129 Million
Q1 2021

Apr 26, 2021

SELL
$153.07 - $170.48 $6.38 Million - $7.11 Million
-41,696 Reduced 4.35%
917,823 $151 Million
Q4 2020

Jan 25, 2021

BUY
$137.11 - $157.38 $1.41 Million - $1.62 Million
10,298 Added 1.08%
959,519 $151 Million
Q3 2020

Oct 20, 2020

SELL
$140.38 - $153.83 $3.37 Million - $3.7 Million
-24,026 Reduced 2.47%
949,221 $141 Million
Q2 2020

Jul 27, 2020

BUY
$128.81 - $155.51 $1.32 Million - $1.6 Million
10,277 Added 1.07%
973,247 $137 Million
Q1 2020

Apr 17, 2020

BUY
$111.14 - $153.99 $2.45 Million - $3.4 Million
22,055 Added 2.34%
962,970 $126 Million
Q4 2019

Jan 17, 2020

SELL
$127.5 - $146.44 $4.6 Million - $5.28 Million
-36,047 Reduced 3.69%
940,915 $137 Million
Q3 2019

Oct 17, 2019

SELL
$126.95 - $142.14 $2.72 Million - $3.05 Million
-21,447 Reduced 2.15%
976,962 $126 Million
Q2 2019

Jul 12, 2019

SELL
$131.15 - $144.24 $4.28 Million - $4.71 Million
-32,631 Reduced 3.16%
998,409 $139 Million
Q1 2019

Apr 17, 2019

SELL
$125.72 - $139.79 $2.59 Million - $2.88 Million
-20,591 Reduced 1.96%
1,031,040 $144 Million
Q4 2018

Jan 17, 2019

BUY
$122.84 - $147.84 $5.37 Million - $6.46 Million
43,691 Added 4.33%
1,051,631 $136 Million
Q3 2018

Oct 16, 2018

BUY
$121.58 - $142.88 $2.03 Million - $2.38 Million
16,684 Added 1.68%
1,007,940 $139 Million
Q2 2018

Jul 19, 2018

SELL
$119.4 - $131.76 $4.26 Million - $4.7 Million
-35,677 Reduced 3.47%
991,256 $120 Million
Q1 2018

Apr 10, 2018

SELL
$125.1 - $148.14 $439,351 - $520,267
-3,512 Reduced 0.34%
1,026,933 $132 Million
Q4 2017

Jan 12, 2018

SELL
$131.22 - $143.62 $2.13 Million - $2.33 Million
-16,235 Reduced 1.55%
1,030,445 $144 Million
Q3 2017

Oct 13, 2017

BUY
$129.47 - $135.38 $136 Million - $142 Million
1,046,680
1,046,680 $136 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $380B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.